Piermont Capital Management’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-26,040
Closed -$838K 266
2017
Q2
$838K Sell
26,040
-4,620
-15% -$152K 0.24% 176
2017
Q1
$1.06M Buy
+30,660
New +$1.09M 0.25% 150
2015
Q2
Sell
-77,170
Closed -$2.61M 244
2015
Q1
$2.61M Buy
77,170
+1,540
+2% +$53.6K 0.8% 66
2014
Q4
$2.65M Sell
75,630
-970
-1% -$32.7K 0.94% 52
2014
Q3
$2.51M Sell
76,600
-6,090
-7% -$207K 0.97% 34
2014
Q2
$2.81M Buy
+82,690
New +$2.83M 1.1% 23

Other funds holding ACH

Piermont Capital Management's ACH Position: Q3 2017 in Review

Piermont Capital Management sold out of Accendra Health (ACH) in Q3 2017, closing a stake of 26,040 shares — an estimated $838K sold.

Piermont Capital Management first reported a position in ACH in Q2 2014 and held it in 6 quarters. The position peaked at $2.81M in Q2 2014. 260 funds tracked by Wall St. Rank hold ACH as of Q3 2017.

  • Piermont Capital Management reported no remaining Accendra Health position as of Q3 2017 after selling out during the quarter.
  • Piermont Capital Management sold 26,040 Accendra Health shares in Q3 2017, an estimated $838K.
  • Piermont Capital Management first reported a position in Accendra Health in Q2 2014 and held it in 6 quarters.
  • Piermont Capital Management's Accendra Health position peaked at $2.81M in Q2 2014.
  • 260 funds tracked by Wall St. Rank held Accendra Health as of Q3 2017.

Based on Piermont Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.